Omega-3 fatty acids have an anti-inflammatory and adipogenic effect in adipose tissue. They offer systemic benefits in metabolic and chronic inflammatory diseases. By modulating inflammation and improving insulin sensitivity, they can help reduce obesity and associated diseases such as MASLD, cardiovascular disease, gut dysbiosis and immune-mediated disorders.
Autoren
- Jens Dehn
Publikation
- InFo DIABETOLOGIE & ENDOKRINOLOGIE
Related Topics
You May Also Like
- Wound treatment and dermal defect coverage
Fish skin matrix for the treatment of complex ulcers
- Well-being of the medical profession in primary care
Findings of a nationwide survey in Switzerland
- Severe asthma and CRSwNP
Multidisciplinary collaboration between pneumology, allergology and ENT
- Myelofibrosis
New findings on the role of inflammation in pathogenesis
- Incretin mimetics for obesity and prediabetes
Liraglutide, semaglutide and tirzepatide: considerable evidence base
- Treatment of infected wounds and wounds at risk of infection
Focus on an interdisciplinary perspective
- Chronic and hard-to-heal wounds
Benefit from the advantages of outpatient negative pressure wound therapy
- COPD